- Trials with a EudraCT protocol (404)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
404 result(s) found for: Lipid profile.
Displaying page 1 of 21.
EudraCT Number: 2007-007491-42 | Sponsor Protocol Number: 2418/2007 | Start Date*: 2008-01-21 | |||||||||||
Sponsor Name:Istituto Fisiologia Clinica, CNR | |||||||||||||
Full Title: GAMMAGLUTAMYLTRANSFERASE: CHARACTERIZATION OF ITS ISOFORMS IN DYSLIPIDEMICS UNDERGOING LIPID-LOWERING TREATMENT | |||||||||||||
Medical condition: Dislipidemiae (hypercholesteremia, hypertriglyceridemia or mixed forms) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005747-29 | Sponsor Protocol Number: BP20843 | Start Date*: 2007-03-14 | ||||||||||||||||
Sponsor Name:F. HOFFMANN-LA ROCHE LTD | ||||||||||||||||||
Full Title: Evaluation of the relationship between HDL quantity and HDL functionality in patients treated with HDL-C raising drugs | ||||||||||||||||||
Medical condition: Primary hypercholesterolemia or mixed dyslipidemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003406-10 | Sponsor Protocol Number: BC21144 | Start Date*: 2007-12-13 | |||||||||||
Sponsor Name:F.Hoffmann-La Roche Ltd. | |||||||||||||
Full Title: A Phase IIb, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study, Evaluating the Safety, Tolerability and Efficacy of RO4607381 by Measuring Flow Mediated Dilatation in the Brachial Ar... | |||||||||||||
Medical condition: Patients with Coronary Heart Disease (CHD) or CHD Risk Equivalents | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NL (Completed) DE (Completed) IT (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003281-84 | Sponsor Protocol Number: EXCRETE | Start Date*: 2018-03-27 |
Sponsor Name:Academical Medical Centre, department of internal | ||
Full Title: The Effect of UrsodeoXyCholicacid (UDCA) and ezetimibe on total faecal steRol ExcreTion and plasma lipid lEvels | ||
Medical condition: Familial hypercholesterolemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005602-10 | Sponsor Protocol Number: 1.1 | Start Date*: 2022-01-20 |
Sponsor Name:Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB) | ||
Full Title: POESIA Study: Pleiotropic effects of PCSK 9 inhibition and bempedoic acid - Changes in Platelet Function and Inflammation Markers | ||
Medical condition: platelet activity and inflammation markers in patients with coronary artery disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002715-10 | Sponsor Protocol Number: FAR-NP-2018-01 | Start Date*: 2019-02-08 |
Sponsor Name:Elisabet Leiva Badosa. Phamacy Department. Hospital Universitari de Bellvitge | ||
Full Title: RANDOMIZED, DOUBLE-BLIND, PILOT CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF FISH OIL-BASED INTRAVENOUS LIPID EMULSIONS IN HOSPITALIZED ADULT PATIENTS TREATED WITH TOTAL PARENTERAL NUTRITIO... | ||
Medical condition: Hypertriglyceridemia is a frequent metabolic complication associated with the administration of lipidic emulsion in total parenteral nutrition. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005066-36 | Sponsor Protocol Number: 12-17 | Start Date*: 2013-05-15 |
Sponsor Name:VU University Medical Center | ||
Full Title: Effect of Growth Hormone replacement therapy on cardiovascular risk factors in adult patients with severe growth hormone deficiency: association with IGF-I concentration | ||
Medical condition: Growth hormone deficiency | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001243-27 | Sponsor Protocol Number: 77108 | Start Date*: 2021-12-09 |
Sponsor Name:Radboudumc | ||
Full Title: Effect of oral magnesium supplementation on insulin sensitivity in people with type 2 diabetes | ||
Medical condition: People with type 2 diabetes mellitus who are treated with insulin and have a low serum magnesium concentration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003311-32 | Sponsor Protocol Number: F 0106 | Start Date*: 2008-02-01 |
Sponsor Name:FORIM GmbH | ||
Full Title: Comparative surveillance study to assess the effect of lipid based nutrition vs. standard regimen on clinical outcome in ventilated patients. | ||
Medical condition: The aim of the presented surveillance is to confirm the results of the pilot study showing a significant reduction in respirator days and ICU-stay in patients with lipid based nutrition compared to... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002418-12 | Sponsor Protocol Number: CFEM345D2407 | Start Date*: 2005-01-25 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: An open-label, randomized, multicenter safety study to evaluate the skeletal and lipid profile effects of letrozole and tamoxifen in postmenopausal women with resected, receptor positive early brea... | ||
Medical condition: Bone loss attributed to cessation of ovarian estrogen production is common in postmenopausal women. In postmenopausal women with breast cancer, treatment with an aromatase inhibitor may further red... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000981-12 | Sponsor Protocol Number: ALIROCKS_05MAR2018_V3 | Start Date*: 2018-05-11 |
Sponsor Name:Medical University of Graz | ||
Full Title: A PILOT STUDY INVESTIGATING THE EFFECTS OF LIPID-THERAPY INTENSIFICATION WITH ALIROCUMAB ON ENDOTHELIAL FUNCTION, CAROTID ARTERIES, LIPOPROTEIN PARTICLE SUBFRACTIONS, INFLAMMATION AND POST-PRANDIAL... | ||
Medical condition: Primary Hypercholesterolemia in secondary prevention after an acute atherosclerotic, ischaemic cardiovascular event for patients with diagnostically confirmed coronary heart disease and / or periph... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001881-10 | Sponsor Protocol Number: RAPHAEL study | Start Date*: 2008-05-27 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Raltegravir/Atazanavir pharmacokinetics and evaluation of lipids | |||||||||||||
Medical condition: chronic HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002319-13 | Sponsor Protocol Number: EfaRiLipidomics | Start Date*: 2015-08-28 | |||||||||||
Sponsor Name:Fundació Hospital Vall Hebron Institut de Recerca | |||||||||||||
Full Title: Outcome of plasma lipid profile in patients switching from Atripla® to Eviplera® compared to continuing on Atripla® (EfaRiLipidomics) | |||||||||||||
Medical condition: HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002607-17 | Sponsor Protocol Number: TSX/01/C | Start Date*: 2005-11-18 |
Sponsor Name:Prostrakan Pharmaceuticals Ltd | ||
Full Title: Effect of Transdermal Testosterone Replacement in Hypogonadal Men with either Metabolic Syndrome or Type 2 Diabetes Mellitus | ||
Medical condition: Male hypogonadism is generally characterised by abnormally low serum testosterone levels. Symptoms include changes in mood, decreased bone mineral density, increased body fat, decreased muscle mass... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) DE (Completed) BE (Completed) ES (Completed) SE (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004946-13 | Sponsor Protocol Number: Taglumet | Start Date*: 2020-08-20 |
Sponsor Name:Univeristy Hospital Tuebingen | ||
Full Title: Conversion to extended-release MeltDose® tacrolimus after kidney transplantation - impact on glucose metabolism and lipid profile | ||
Medical condition: stable adult kidney transplant | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015729-35 | Sponsor Protocol Number: PCOS&Niacin | Start Date*: 2009-11-23 |
Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust | ||
Full Title: TO DETERMINE IF CARDIOVASCULAR RISK INDICES INCLUDING POSTPRANDIAL HYPERTRIGLYCERIDAEMIA ARE MODIFIED FAVOURABLY BY NICOTINIC ACID (NIACIN) IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME (PCOS) | ||
Medical condition: Polycystic ovary syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001690-26 | Sponsor Protocol Number: v30 | Start Date*: 2005-02-11 |
Sponsor Name:Craigavon Area Hospital Group Trust | ||
Full Title: The Low HDL On six Weeks statin therapy (LOW) study | ||
Medical condition: Dyslipidaemia (low HDL-cholesterol) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004525-99 | Sponsor Protocol Number: ESD | Start Date*: 2004-11-09 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: A randomized, prospective, double-blind study to evaluate the effects on lipid profile of combined Ezetimibe and Simvastatin therapy as compared to Simvastatin alone in people with type 2 diabetes | |||||||||||||
Medical condition: Effects of Ezetimibe-simvastatin combined therapy in ameliorating the lipid profile and the overall cardiovascular and renal risk profile of patients with type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003397-82 | Sponsor Protocol Number: HC-G-H-0813 | Start Date*: 2012-12-12 | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: Prospective, randomized, controlled, double-blind, parallel-group, mono-centre, explorative Phase IV trial on the efficacy and safety of a fish oil containing lipid emulsion versus a standard soybe... | |||||||||||||
Medical condition: Acute Lung Injury as a result of proven pneumonia (x-ray) or witnessed aspiration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005064-22 | Sponsor Protocol Number: TA-8995-301 | Start Date*: 2022-09-22 | ||||||||||||||||
Sponsor Name:NewAmsterdam Pharma B.V. | ||||||||||||||||||
Full Title: Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies (BROOKLYN): A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Partici... | ||||||||||||||||||
Medical condition: dyslipidemia heterozygous familial hypercholesterolemia (HeFH) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) NL (Completed) CZ (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
